According to RPG Life Sciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.66089. At the end of 2023 the company had a P/S ratio of 3.98.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.98 | 45.7% |
2022 | 2.73 | 13.55% |
2021 | 2.41 | 46.78% |
2020 | 1.64 | 13.42% |
2019 | 1.45 | 28.6% |
2018 | 1.12 | -53.62% |
2017 | 2.42 | -9.94% |
2016 | 2.69 | 50.22% |
2015 | 1.79 | 183.48% |
2014 | 0.6320 | 35.24% |
2013 | 0.4673 |